AQbD‐Optimized Chiral HPLC for Ruxolitinib Purity Control

Ruxolitinib phosphate (RUX) is a potent Janus kinase (JAK) inhibitor whose strict stereoselective pharmacodynamics necessitate rigorous enantiomeric purity control during pharmaceutical manufacturing. Although foundational enantioseparations of RUX have been previously reported, there remains a critical lack of robust quantitative assays capable of trace‐level impurity monitoring. To address this gap, the primary novelty of this study lies in the establishment of a rigorously validated normal‐phase high‐performance liquid chromatography (NP‐HPLC) method specifically tailored for the trace‐level determination of the ( S )‐enantiomer. Engineered via an analytical quality by design (AQbD) framework, the methodology sequentially deployed fractional factorial design (FFD) and face‐centered central composite design (FCCD). Through this approach, key thermodynamic and kinetic parameters were mathematically modeled to delineate a resilient method operable design region (MODR). Optimal stereoselective discrimination was achieved on a CHIRALCEL OD‐H stationary phase utilizing an isocratic n‐hexane/ethanol (92:8, v/v) eluent, yielding baseline enantiomeric resolution (R s ≈ 3.0) within a run time (RT) of 20 min. Methodological reliability was comprehensively verified utilizing the total error approach, demonstrating trueness, precision, and sensitive quantitation limits of 0.50 μg mL −1 for ( S )‐enantiomer. Finally, method robustness against matrix interference was empirically confirmed via standard addition on commercial formulations, demonstrating its fit‐for‐purpose utility for routine quality control.

Authors

Institutions

Publication Details

Journal
Chirality
Published
2026-11-18
DOI
https://doi.org/10.1002/chir.70164
Primary Topic
Analytical Chemistry and Chromatography
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AQbD‐Optimized Chiral HPLC for Ruxolitinib Purity Control

Roula Bayram, Reham Ali, Jawaher Abdullah Alamoudi, Ahmed M. Ibrahim et al.
Chirality
Analytical Chemistry and Chromatography
article

AQbD‐Optimized Chiral HPLC for Ruxolitinib Purity Control

Roula Bayram, Reham Ali, Jawaher Abdullah Alamoudi, Ahmed M. Ibrahim, Asmaa Saleh
article en

Abstract

Ruxolitinib phosphate (RUX) is a potent Janus kinase (JAK) inhibitor whose strict stereoselective pharmacodynamics necessitate rigorous enantiomeric purity control during pharmaceutical manufacturing. Although foundational enantioseparations of RUX have been previously reported, there remains a critical lack of robust quantitative assays capable of trace‐level impurity monitoring. To address this gap, the primary novelty of this study lies in the establishment of a rigorously validated normal‐phase high‐performance liquid chromatography (NP‐HPLC) method specifically tailored for the trace‐level determination of the ( S )‐enantiomer. Engineered via an analytical quality by design (AQbD) framework, the methodology sequentially deployed fractional factorial design (FFD) and face‐centered central composite design (FCCD). Through this approach, key thermodynamic and kinetic parameters were mathematically modeled to delineate a resilient method operable design region (MODR). Optimal stereoselective discrimination was achieved on a CHIRALCEL OD‐H stationary phase utilizing an isocratic n‐hexane/ethanol (92:8, v/v) eluent, yielding baseline enantiomeric resolution (R s ≈ 3.0) within a run time (RT) of 20 min. Methodological reliability was comprehensively verified utilizing the total error approach, demonstrating trueness, precision, and sensitive quantitation limits of 0.50 μg mL −1 for ( S )‐enantiomer. Finally, method robustness against matrix interference was empirically confirmed via standard addition on commercial formulations, demonstrating its fit‐for‐purpose utility for routine quality control.

ChiralityVol. 38(12)
Princess Nourah bint Abdulrahman University (SA), University of Aleppo (SY), Qassim University (SA), Batterjee Medical College (SA), Egyptian Drug Authority (EG)
Analytical Chemistry and Chromatography
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon